Literature DB >> 16354006

Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.

Maria Letizia Manca1, Marco Zaru, Guido Ennas, Donatella Valenti, Chiara Sinico, Giuseppe Loy, Anna Maria Fadda.   

Abstract

The aim of this work was to study the influence of beta-cyclodextrin (beta-CD) on the biopharmaceutic properties of diclofenac (DCF). To this purpose the physicochemical characterization of diclofenac-beta-cyclodextrin binary systems was performed both in solution and solid state. Solid phase characterization was performed using differential scanning calorimetry (DSC), powder x-ray diffractometry (XRD), and Fourier transform infrared spectroscopy (FTIR). Phase solubility analyses, and in vitro permeation experiments through a synthetic membrane were performed in solution. Moreover, DCF/beta-CD interactions were studied in DMSO by 1H nuclear magnetic resonance (NMR) spectroscopy. The effects of different preparation methods and drug-to-beta-CD molar ratios were also evaluated. Phase solubility studies revealed 1:1 M complexation of DCF when the freeze-drying method was used for the preparation of the binary system. The true inclusion for the freeze-dried binary system was confirmed by 1H NMR spectroscopy, DSC, powder XRD, and IR studies. The dissolution study revealed that the drug dissolution rate was improved by the presence of CDs and the highest and promptest release was obtained with the freeze-dried binary system. Diffusion experiments through a silicone membrane showed that DCF diffusion was higher from the saturated drug solution (control) than the freeze-dried inclusion complexes, prepared using different DCF-beta-CD molar ratios. However, the presence of the inclusion complex was able to stabilize the system giving rise to a more regular diffusion profile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354006      PMCID: PMC2750392          DOI: 10.1208/pt060358

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

1.  Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation.

Authors:  R Ficarra; P Ficarra; M R Di Bella; D Raneri; S Tommasini; M L Calabrò; M C Gamberini; C Rustichelli
Journal:  J Pharm Biomed Anal       Date:  2000-08-01       Impact factor: 3.935

2.  Cyclodextrins in nasal drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

3.  Cyclodextrins in transdermal and rectal delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

4.  Cyclodextrins in ophthalmic drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

5.  Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems.

Authors:  P Mura; M T Faucci; P L Parrini; S Furlanetto; S Pinzauti
Journal:  Int J Pharm       Date:  1999-03-01       Impact factor: 5.875

6.  Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.

Authors:  M Másson; T Loftsson; G Másson; E Stefánsson
Journal:  J Control Release       Date:  1999-05-01       Impact factor: 9.776

7.  Membrane penetration enhancement of ibuprofen using supersaturation.

Authors:  M Iervolino; S L Raghavan; J Hadgraft
Journal:  Int J Pharm       Date:  2000-04-05       Impact factor: 5.875

8.  Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.

Authors:  Alka Pravin Mukne; M S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2004-03-29       Impact factor: 3.246

9.  Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.

Authors:  Catarina M Fernandes; Rui A Carvalho; Saúl Pereira da Costa; Francisco J B Veiga
Journal:  Eur J Pharm Sci       Date:  2003-04       Impact factor: 4.384

10.  Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.

Authors:  P Jarho; K Järvinen; A Urtti; V J Stella; T Järvinen
Journal:  J Pharm Pharmacol       Date:  1996-03       Impact factor: 3.765

View more
  5 in total

1.  Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.

Authors:  Abdul Ahad; Yousef A Bin Jardan; Mohd Zaheen Hassan; Mohammad Raish; Ajaz Ahmad; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.

Authors:  Fareen Sami; Betty Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

3.  Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.

Authors:  Samir G Patel; Sadhana J Rajput
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

Review 4.  Perspectives in solubility measurement and interpretation.

Authors:  Christel A S Bergström; Alex Avdeef
Journal:  ADMET DMPK       Date:  2019-04-05

5.  Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCl Inclusion Complexes.

Authors:  Sj George; Dt Vasudevan
Journal:  J Young Pharm       Date:  2012-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.